Beyond the Beam: A Radiation Oncology Curriculum for Radiopharmaceutical Therapy

April 26, 3:00 p.m. - 5:00 p.m. Eastern time – Introduction, Radiobiology I and Chemistry

• Introduction to radiopharmaceutical therapy and curriculum overview – Ana Kiess, MD, PhD
• Radiobiology I – PK, biodistribution, dose rate, subcellular targeting, molecular and cellular effects of beta/alpha deterministic and stochastic effects, toxicities – Ana Kiess, MD, PhD
• Chemistry of radiopharmaceutical therapies for medical use – Freddy E. Escorcia, MD, PhD

May 10, 3:00 p.m. - 5:00 p.m. Eastern time – Physics l and Principles of Molecular Imaging

• Physics I – Image acquisitions and quantitation (PET, SPECT) – Rameshwar Prasad, MS, PhD
• Principles of clinical molecular imaging for radiopharmaceutical therapy – Vikas Prasad, MD, PhD 

May 17, 3:00 p.m. - 5:00 p.m. Eastern time – Physics ll, lll and IV

• Physics II – Instrumentation and mathematics pertaining to the use of measurement of radioactivity – Rameshwar Prasad, MS, PhD
• Physics lll – Radiation protection for radiopharmaceutical therapies – Jessica Clements, MS 
• Physics IV – Regulatory issues and standard operating procedures – Jacqueline Esthappan Zoberi, PhD 

May 24, 3:00 p.m. - 5:00 p.m. Eastern time – Dosimetry l and ll and Radiobiology II

• Dosimetry l – Dosimetry methods and individual dose planning uncertainties – Yuni Dewaraja, PhD
• Dosimetry II/Radiobiology ll – Bioeffect modeling. Tumor dose-response. Toxicities. Alpha emitters – Robert Francois Hobbs, PhD

May 31, 3:00 p.m. - 4:00 p.m. Eastern time – Quality and Safety

• Principles of patient-centered clinical radiopharmaceutical therapy quality and safety – Hyun Kim, MD

June 7, 3:00 p.m. - 5:00 p.m. Eastern time – Therapy-Specific Considerations l

• Therapy-specific considerations for Lu-PSMA-617 – Jeff Michalski, MD, MBA, FASTRO
• Therapy-specific considerations for Ra-223 – Richard G. Stock, MD

June 14, 3:00 p.m. - 5:00 p.m. Eastern time – Therapy-Specific Considerations ll

• Therapy-specific considerations for RAI – Stephanie Markovina, MD, PhD, and Nikhil Rammohan, MD, PhD
• Therapy-specific considerations for liver-directed radiopharmaceutical therapy/selective internal radiation therapy – Andrew S. Kennedy, MD

June 28, 3:00 p.m. - 4:00 p.m. Eastern time – Miscellaneous and Future Applications

• Miscellaneous and future applications of radiopharmaceutical therapy – How to become an authorized user. Meta-iodobenzylguanidine. Rhenium skin cancer therapy. Radiosynoviorthesis. Alpha emitters. Other – Michael Folkert, MD, PhD

July 5, 3:00 p.m. - 4:00 p.m. Eastern time – Therapy-Specific Considerations lll

• Therapy-specific considerations for Lu-DOTATATE – Hyun Kim, MD